Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Moleculin Biotech MBRX Stock Market Movement Slight Rise 20260420 John HPI Stock Continuation Trade Trend Strengthens 20260422 CBU CommunityFin posts 98 percent Q4 2025 EPS miss sending shares down 127 percent today US Bancorp USB Expands Healthcare Practice Lending with New Startup Loan Product Duos Tech DUOT posts sharp Q4 earnings miss loss widens to negative 015 versus estimate GFAI Guardforce shares drop 525 despite 8 revenue growth as net loss concerns linger Generative AI Sector Regulatory Risk Update Criminal Probe of Leading Developer Over Public Safety Liability Claims State Street SPDR SP Software Services ETF XSW 2026 Performance Assessment and Strategic Portfolio Positioning Healthcare HCSG Profitability Outlook Q1 2026 Profit Exceeds Views Geopolitical Tensions Escalate Political Executions in Iran Fuel Market Uncertainty Ofcom Fines Suicide Forum 950000 as Online Safety Crackdown Intensifies Trumps China Trade Mission Excludes Nvidia CEO Signaling Ongoing Chip Sector Frictions Stocks and Bonds Slide as Iran Conflict Fuels Inflation Fears and Rate Hike Bets Flexible FSI Down 144 How Low Could It Go 20260521 ST Bancorp STBA Reports Strong Q1 2026 Revenue NA EPS Beats UK Petrol Prices Surge to Highest Level Since Iran Conflict RAC Warns of Further Increases Cabot CBT Delivers Q1 2026 Beat EPS 161 vs 147 Expected AI Infrastructure Spending Drives These 5 Companies Toward 10 Trillion Market Cap by 2030 Biotech Stocks Face Headwinds but TopTier Names Show Resilience Elon Musk Loses HighProfile Legal Battle Against OpenAI Yet Persistence May Continue Bitcoin Slides Below 77000 Amid Iran Peace Uncertainty and ETF Withdrawals Canaccord Genuity Raises Price Target for Biodesix Amid Improved Revenue Outlook Andy Burnhams Manchester Spirit Could a Mix of Collectivism and Entrepreneurialism Reshape UK Policy CMMB Q1 2026 Earnings WiderthanExpected Loss No Revenue Stock Rises 233 ADIL Q1 2026 Earnings Narrowing Loss Beats Estimates But Stock Declines Amid No Revenue HRTX Q1 2026 Earnings EPS Miss Weighs but Stock Gains Slightly CIMN Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Market Reaction NCMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Advertising Environment Silexion Therapeutics Corp Warrant SLXNW Faces Continued Selling Pressure at Penny Level Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance Argo Blockchain ARBK Rebounds from Support Can the Momentum Continue